These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11751703)

  • 1. Angiotensin II type 2 receptors and cardiac hypertrophy in women with hypertrophic cardiomyopathy.
    Deinum J; van Gool JM; Kofflard MJ; ten Cate FJ; Danser AH
    Hypertension; 2001 Dec; 38(6):1278-81. PubMed ID: 11751703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy.
    Osterop AP; Kofflard MJ; Sandkuijl LA; ten Cate FJ; Krams R; Schalekamp MA; Danser AH
    Hypertension; 1998 Nov; 32(5):825-30. PubMed ID: 9822439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy.
    Lechin M; Quiñones MA; Omran A; Hill R; Yu QT; Rakowski H; Wigle D; Liew CC; Sole M; Roberts R
    Circulation; 1995 Oct; 92(7):1808-12. PubMed ID: 7671365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II type 1 receptor gene polymorphisms in patients with cardiac hypertrophy.
    Ishanov A; Okamoto H; Watanabe M; Yoneya K; Nakagawa I; Kumamoto H; Chiba S; Hata A; Kawaguchi H; Kitabatake A
    Jpn Heart J; 1998 Jan; 39(1):87-96. PubMed ID: 9601485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of renin-angiotensin system polymorphisms on development of systolic dysfunction in hypertrophic cardiomyopathy. Evidence from a study of genotyped patients.
    Funada A; Konno T; Fujino N; Muramoto A; Hayashi K; Tsubokawa T; Sakata K; Kawashiri MA; Takeda Y; Ino H; Yamagishi M
    Circ J; 2010 Nov; 74(12):2674-80. PubMed ID: 20975235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac aldosterone in subjects with hypertrophic cardiomyopathy.
    Chai W; Hoedemaekers Y; van Schaik RH; van Fessem M; Garrelds IM; Saris JJ; Dooijes D; ten Cate FJ; Kofflard MM; Danser AH
    J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):225-30. PubMed ID: 17318792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy.
    Perkins MJ; Van Driest SL; Ellsworth EG; Will ML; Gersh BJ; Ommen SR; Ackerman MJ
    Eur Heart J; 2005 Nov; 26(22):2457-62. PubMed ID: 16087648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of angiotensin-converting enzyme activity and polymorphism with echocardiographic measures in familial and nonfamilial hypertrophic cardiomyopathy.
    Buck PC; Fernandes F; Arteaga E; Matsumoto AY; Araujo AQ; Oliveira EM; Ianni BM; Ramires FJ; Krieger JE; Mady C
    Braz J Med Biol Res; 2009 Aug; 42(8):717-21. PubMed ID: 19390744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in angiotensin II type 2 receptor gene influences extent of left ventricular hypertrophy in hypertrophic cardiomyopathy independent of blood pressure.
    Carstens N; van der Merwe L; Revera M; Heradien M; Goosen A; Brink PA; Moolman-Smook JC
    J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):274-80. PubMed ID: 21163866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE and AGTR1 polymorphisms and left ventricular hypertrophy in endurance athletes.
    Di Mauro M; Izzicupo P; Santarelli F; Falone S; Pennelli A; Amicarelli F; Calafiore AM; Di Baldassarre A; Gallina S
    Med Sci Sports Exerc; 2010 May; 42(5):915-21. PubMed ID: 19997001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients.
    Benetos A; Gautier S; Ricard S; Topouchian J; Asmar R; Poirier O; Larosa E; Guize L; Safar M; Soubrier F; Cambien F
    Circulation; 1996 Aug; 94(4):698-703. PubMed ID: 8772690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population.
    Paillard F; Chansel D; Brand E; Benetos A; Thomas F; Czekalski S; Ardaillou R; Soubrier F
    Hypertension; 1999 Sep; 34(3):423-9. PubMed ID: 10489388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of left ventricular hypertrophy and the angiotensin-converting enzyme gene polymorphism in hypertrophic cardiomyopathy.
    Doolan G; Nguyen L; Chung J; Ingles J; Semsarian C
    Int J Cardiol; 2004 Aug; 96(2):157-63. PubMed ID: 15314809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variants of trophic factors and expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy.
    Patel R; Lim DS; Reddy D; Nagueh SF; Lutucuta S; Sole MJ; Zoghbi WA; Quiñones MA; Roberts R; Marian AJ
    J Mol Cell Cardiol; 2000 Dec; 32(12):2369-77. PubMed ID: 11113012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension.
    Pontremoli R; Ravera M; Viazzi F; Nicolella C; Berruti V; Leoncini G; Giacopelli F; Bezante GP; Sacchi G; Ravazzolo R; Deferrari G
    Kidney Int; 2000 Feb; 57(2):561-9. PubMed ID: 10652033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial hypertrophic cardiomyopathy. Insertion-deletion polymorphism of angiotensin-converting enzyme and angiotensin II receptor.
    Gilanowska G; Domal-Kwiatkowska D; Smolik S; Wilczewski P; Szarek J; Nowalany-Kozielska E; Mazurek U; Wodniecki J; Wilczok T
    Kardiol Pol; 2005 May; 62(5):440-9; 449-50. PubMed ID: 15928721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy.
    Brugada R; Kelsey W; Lechin M; Zhao G; Yu QT; Zoghbi W; Quinones M; Elstein E; Omran A; Rakowski H; Wigle D; Liew CC; Sole M; Roberts R; Marian AJ
    J Investig Med; 1997 Dec; 45(9):542-51. PubMed ID: 9444881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of renin-angiotensin-aldosterone system polymorphisms in phenotypic expression of MYBPC3-related hypertrophic cardiomyopathy.
    Kolder IC; Michels M; Christiaans I; Ten Cate FJ; Majoor-Krakauer D; Danser AH; Lekanne Deprez RH; Tanck M; Wilde AA; Bezzina CR; Dooijes D
    Eur J Hum Genet; 2012 Oct; 20(10):1071-7. PubMed ID: 22569109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes].
    Buraczyńska M; Ksiazek P; Łopatyński J; Spasiewicz D; Nowicka T; Ksiazek A
    Pol Arch Med Wewn; 2002 Aug; 108(2):725-30. PubMed ID: 12476891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease.
    Buraczyńska M; Pijanowski Z; Spasiewicz D; Nowicka T; Sodolski T; Widomska - Czekajska T; Ksiazek A
    Kardiol Pol; 2003 Jan; 58(1):1-9. PubMed ID: 14502296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.